Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism

Conditions

Alcoholism

What is the purpose of this trial?

The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high risk individuals that may lead to the transition from moderate to excessive use of alcohol.



Participation Guidelines

Age:
21 Years - 30 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
VA Connecticut Healthcare System
Yale University
Dates:
March 2001
Last Updated:
February 14, 2013
Study HIC#:
0304025194

Clinicaltrials.gov ID: NCT00612352